Published date: 11 September 2024

Last edited date: 11 September 2024

Closed early engagement


Closing date: 21 October 2024

Contract summary

Industry

  • Human blood - 33141570

  • Repair and maintenance services of medical and surgical equipment - 50420000

Location of contract

BS34 7QH

Procurement reference

CF-2586100D0O000000rwimUAA

Published date

11 September 2024

Closing date

21 October 2024

Contract type

Service contract

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

This Prior Information Notice (PIN) is separate to any tender opportunity.
The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.
The purpose of this notice is to:
• Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases.
• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support.
Please express your interest by the 2nd October 2024 and direct any questions to tennille.madigan@nhsbt.nhs.uk

More information

Previous notice about this procurement

Supply & Maintenance of New & Maintenance of Existing Cell Selection Systems

  • Early engagement
  • Published 11 September 2024

Additional text

This Prior Information Notice (PIN) is separate to any tender opportunity.
The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures.
The purpose of this notice is to:
• Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases.
• Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support.
Please express your interest by the 2nd October 2024 and direct any questions to tennille.madigan@nhsbt.nhs.uk

About the buyer

Contact name

Tennille Madigan

Address

NHS Blood and Transplant, Bristol
Bristol
BS34 7QH
United Kingdom

Telephone

07795483583

Email

tennille.madigan@nhsbt.nhs.uk